Nabumétone Tillomed (Nabumetone)

Nabumetone, the active ingredient in Nabumétone Tillomed, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis and other musculoskeletal pain conditions in adult patients.

GNH USA supplies Nabumétone Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nabumetone is an NSAID that reduces inflammation and pain in several joint and musculoskeletal disorders.

- Osteoarthritis: alleviates joint pain and stiffness, improving functional ability. - Rheumatoid arthritis: decreases synovial inflammation and swelling, helping to preserve joint mobility. - Musculoskeletal pain: provides analgesic relief for acute or chronic soft‑tissue discomfort.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Nausea or mild vomiting. - Headache. - Dizziness. - Transient rash.

Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding. - Elevated liver enzymes or hepatitis. - Acute renal impairment. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or severe allergic reactions. - Cardiovascular events including hypertension or thrombotic episodes.

Before initiating therapy, clinicians should consider several safety measures.

- Assess renal function: evaluate creatinine clearance in patients with kidney disease. - Monitor hepatic enzymes: check liver function tests periodically. - Use the lowest effective dose: limit exposure to reduce risk of adverse events. - Avoid in active peptic ulcer disease: NSAIDs can exacerbate ulceration. - Review concomitant anticoagulant or antiplatelet use: increased bleeding risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nabumetone may interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Warfarin or other anticoagulants: heightened bleeding risk. - Concurrent NSAIDs or aspirin: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: possible reduction in renal function. - Lithium: increased serum lithium concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: monitor renal function and electrolytes. - Methotrexate: potential for increased toxicity. - Systemic corticosteroids: enhanced risk of gastrointestinal ulceration.